利农生物 (872212.OC)

+ 收藏

现金流量表(利农生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 29,575,975.1685,253,252.3135,749,776.5879,610,680.1323,993,233.02
 收到的税费返还(元) ----14,997.34
 收到其他与经营活动有关的现金(元) 600,454.043,260,440.101,782,484.8413,266,487.1715,239,563.22
 经营活动现金流入小计(元) 30,176,429.2088,513,692.4137,532,261.4292,877,167.3039,247,793.58
 购买商品、接受劳务支付的现金(元) 11,355,248.2647,282,537.8919,562,766.6948,486,730.074,215,518.52
 支付给职工以及为职工支付的现金(元) 5,839,686.489,800,623.865,444,620.278,652,567.805,121,151.15
 支付的各项税费(元) 21,557.4165,501.0121,626.5842,192.8423,155.91
 支付其他与经营活动有关的现金(元) 2,076,043.7414,735,795.954,334,772.9016,324,917.5513,090,702.53
 经营活动现金流出小计(元) 19,292,535.8971,884,458.7129,363,786.4473,506,408.2622,450,528.11
 经营活动产生的现金流量净额(元) 10,883,893.3116,629,233.708,168,474.9819,370,759.0416,797,265.47
二、投资活动产生的现金流量
 购建固定资产、无形资产和其他长期资产支付的现金(元) 1,272,914.772,667,571.892,873,505.4711,999,884.542,640,939.70
 支付其他与投资活动有关的现金(元) --50,000.00--
 投资活动现金流出小计(元) 1,272,914.772,667,571.892,923,505.4711,999,884.542,640,939.70
 投资活动产生的现金流量净额(元) -1,272,914.77-2,667,571.89-2,923,505.47-11,999,884.54-2,640,939.70
三、筹资活动产生的现金流量
 取得借款收到的现金(元) 5,000,000.00-5,000,000.0014,900,000.006,900,000.00
 筹资活动现金流入小计(元) 5,000,000.00-5,000,000.0014,900,000.006,900,000.00
 偿还债务支付的现金(元) 7,250,001.347,704,666.687,076,333.3413,831,000.0011,587,000.00
 分配股利、利润或偿付利息支付的现金(元) 11,375,369.64905,386.91514,347.156,354,087.165,968,896.34
 支付其他与筹资活动有关的现金(元) -3,767,161.64-3,836,114.52-
 筹资活动现金流出小计(元) 18,625,370.9812,377,215.237,590,680.4924,021,201.6817,555,896.34
 筹资活动产生的现金流量净额(元) -13,625,370.98-12,377,215.23-2,590,680.49-9,121,201.68-10,655,896.34
四、汇率变动对现金及现金等价物的影响(元) -24,382.98---
五、现金及现金等价物净增加额(元) -4,014,392.441,608,829.562,654,289.02-1,750,327.183,500,429.43
 加:期初现金及现金等价物余额(元) 5,899,840.564,086,486.904,086,486.905,836,814.085,836,814.08
 期末现金及现金等价物余额(元) 1,885,448.125,695,316.466,740,775.924,086,486.909,337,243.51
补充资料:
 净利润(元) 656,189.6915,906,599.953,363,072.322,373,671.36166,507.71
 资产减值准备(元) --739,010.96120,382.561,191,807.02698,680.50
 固定资产和投资性房地产折旧(元) 1,239,086.972,582,223.161,342,550.962,151,876.311,786,412.40
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 1,239,086.972,582,223.161,342,550.962,151,876.311,786,412.40
 无形资产摊销(元) 118,333.3834,722.213,333.33--
 长期待摊费用摊销(元) 746,176.081,462,395.28758,373.062,700,453.572,484,141.80
 处置固定资产、无形资产和其他长期资产的损失(元) -497,196.48---
 固定资产报废损失(元) ---12,012.00-
 财务费用(元) 316,263.84871,194.17514,347.15837,604.04439,343.44
 存货的减少(元) 2,056,700.12-4,619,155.141,124,316.15-13,612,761.245,883,367.43
 经营性应收项目的减少(元) 2,949,745.941,937,028.07-4,221,430.687,954,568.052,218,067.51
 经营性应付项目的增加(元) 249,624.43-4,751,193.30-5,209,018.6211,730,603.171,576,641.91
 现金的期末余额(元) 1,885,448.125,695,316.466,740,775.924,086,486.909,337,243.51
 减:现金的期初余额(元) 5,899,840.564,086,486.904,086,486.905,836,814.085,836,814.08
 现金及现金等价物的净增加额(元) -4,014,392.441,608,829.562,654,289.02-1,750,327.183,500,429.43
公告日期 2024-08-262024-04-222023-08-242023-04-242022-08-23
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院